About Sonociné
Sonociné: Revolutionizing Breast Cancer Screening with Ultrasound Technology
Breast cancer is one of the most common types of cancer affecting women worldwide. Early detection is crucial for successful treatment and survival rates, but traditional mammography screening methods have limitations. Sonociné, a leading medical technology company, has developed an innovative ultrasound breast cancer screening technology that offers a more accurate and comfortable alternative to mammography.
Founded in 1999 by Dr. Kevin M. Kelly, Sonociné has been at the forefront of breast cancer screening technology for over two decades. The company's mission is to provide women with a safe and effective way to detect breast cancer early, when it's most treatable.
Sonociné's patented Automated Whole Breast Ultrasound (AWBUS) system uses high-frequency sound waves to create detailed images of the entire breast tissue without radiation exposure or compression. Unlike mammography, which can miss up to 20% of cancers in dense breasts or produce false positives due to overlapping tissue or benign abnormalities, AWBUS provides a comprehensive view of the breast tissue from multiple angles.
The AWBUS exam takes about 30 minutes and involves lying on your back while a trained technician moves an ultrasound probe over your breasts. The images are then analyzed by radiologists who specialize in breast imaging using advanced computer-aided detection software that highlights any suspicious areas for further evaluation.
One of the key advantages of AWBUS is its ability to detect small cancers that may not be visible on mammograms until they have grown larger or spread beyond the breast tissue. Studies have shown that adding AWBUS to routine mammography can increase cancer detection rates by up to 50% in women with dense breasts or other high-risk factors.
Another benefit of AWBUS is its non-invasive nature and lack of discomfort compared to mammography's compression technique which can cause pain and anxiety for some women. This makes it an ideal option for those who may avoid regular screenings due to fear or discomfort associated with traditional methods.
Sonociné also offers training programs for healthcare professionals interested in incorporating AWBUS into their practice as well as patient education resources on their website including FAQs about what happens during an exam and how often you should get screened based on your age and risk factors.
In addition, Sonociné has partnered with several leading healthcare organizations such as Susan G Komen Foundation and American College Of Radiology Imaging Network (ACRIN)to conduct clinical trials evaluating the effectiveness of AWBUS compared with other screening modalities like MRI scans .
Overall, Sonocine’s innovative ultrasound technology provides patients with peace-of-mind knowing they are receiving accurate results while avoiding unnecessary radiation exposure from traditional methods like X-rays used during Mammograms . With its commitment towards improving early detection rates through research partnerships , training programs ,and patient education resources ,it’s no wonder why so many people trust this company when it comes down detecting Breast Cancer .
If you're looking for a more accurate way to screen for breast cancer without discomfort or radiation exposure , consider scheduling an appointment today at one our partner clinics offering this revolutionary new technology!
sonocine.com